| Promoting the Quality of Medicines Plus
The role involves developing monographs for simple inorganic/organic compounds, lipids, essential and fixed oils, fats, minerals, as well as natural, synthetic, and semisynthetic polymers, celluloses, waxes, and clays. It also includes creating physical, chemical, and GDP/GMP-related chapters to support the identification, characterization, supply, and distribution of excipients from development through to pharmaceutical use.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for | Promoting the Quality of Medicines Plus.
| Promoting the Quality of Medicines Plus didn’t post a salary, so this is our estimate from similar listings.
8% above the average for this role